Hanneke Weitering, staff writer for Space.com, breaks down what could go wrong or right during SpaceX's Falcon Heavy launch. The company is planning on launching the rocket from the Kennedy Space Center Tuesday after years of delay.
Weitering says the Falcon Heavy is a "big, awesome rocket" that could eventually take passengers to the moon or even Mars. It was originally set to launch in 2013.
Weitering explains the Falcon Heavy launch is a big deal for space exploration, since the rocket can be reused. The test payload for the rocket is Elon Musk's original Tesla Roadster.
Scott Price, head of international operations for UPS, talked to Cheddar about the delivery giant's capacity for distributing COVID vaccines globally.
The impact of Texas' governor repealing many of the state’s COVID-19 restrictions is beginning to take shape.
Thomas Edison’s most prolific invention is arguably not the lightbulb we all know him for, but the lab in Menlo Park New Jersey that he used to create it.
Mitch Jackson, chief sustainability officer for FedEx, spoke to Cheddar about the delivery giant's $2 billion plan to reach carbon neutrality by 2040.
SpaceX's futuristic Starship has exploded after what looked to be a successful touchdown.
President Joe Biden says the U.S. expects to take delivery of enough coronavirus vaccines for all adult Americans by the end of May, two months earlier than anticipated.
Texas is lifting a COVID-19 mask mandate that was imposed last summer but has only been lightly enforced. Republican Gov. Greg Abbott’s announcement Tuesday makes Texas the largest state to do away with a face covering order.
Drugmaker Merck & Co. will help produce rival Johnson & Johnson’s newly approved coronavirus vaccine in an effort to expand supply more quickly.
The slaughter of nearly 900 cattle that have been stuck on a cargo ship in the Mediterranean for two months has been postponed until Thursday.
Susan Lucas Collins, global head of healthcare services at cloud communications company Twilio, talked to Cheddar about providing tools necessary to help smooth out the somewhat chaotic vaccine rollout in the United States.
